Skip to content

Clinical trials

Completed Diabetes Mellitus, Type 2 trials in the United Arab Emirates

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Status: Completed Country / region: United Arab Emirates Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20092
20104
20112
20123
20132
20144
20152
20164
20172
20181
20192
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S13
Sanofi4
Rashid Centre for Diabetes and Research3
AstraZeneca2
Eli Lilly and Company2
Imperial College London Diabetes Centre2
Janssen Research & Development, LLC1
Janssen-Cilag International NV1
Merck Sharp & Dohme LLC1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 232
Diabetes Mellitus13
Diabetes Mellitus, Type 13
Hypoglycemia2
Acute Coronary Syndrome1
Diabetic Nephropathies1
Disease Progression1
Glucose Metabolism Disorders1
Insulin Resistance1
Kidney Failure, Chronic1

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.